InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by WINDSOR JAMES BRIAN, See Remarks. Insider active across 3 companies, notably Rein Therapeutics, Inc.. In total, 6 reports have been recorded. Split: 5 buys · 0 sell. Total volume traded: €53k. Activity tracked since 20 November 2023. The latest transaction was disclosed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
25,000 shares@ US$1.000.067% mcap50.0% of flowCommon stock , $0.001 par valueSEC:0001193125-26-220718
Ideal exit: 25 Jan 2027 (T+270)
25,000 shares@ US$1.000.067% mcap50.0% of flowCommon stock , $0.001 par valueSEC:0001193125-26-220718:0
Ideal exit: 25 Jan 2027 (T+270)
239 shares@ US$2.24100.0% of flowCommon StockSEC:0000950170-24-134522:0
Ideal exit: 1 Sept 2025 (T+270)
2,000 sharesCommon StockSEC:0000950170-24-027304:0
225 shares@ US$3.377.0% of flowCommon StockSEC:0000950170-23-071200:0
Ideal exit: 10 Sept 2024 (T+270)
5,076 shares@ US$1.967593.0% of flowCommon StockSEC:0000950170-23-065545:0
Ideal exit: 16 Aug 2024 (T+270)
6 of 6 declarations
About WINDSOR JAMES BRIAN
James Brian Windsor is associated with Rein Therapeutics, Inc. His role is noted as 'see remarks', indicating involvement in specific activities within the company. Details of his responsibilities are not provided.
